Bulk Manufacturer of Controlled Substances Application: S&B Pharma, Inc., 11558 [2021-03837]
Download as PDF
<![CDATA[
11558
Federal Register / Vol. 86, No. 36 / Thursday, February 25, 2021 / Notices
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
In
accordance with 21 CFR 1301.33(a), this
is notice that on July 20, 2020, Chattem
Chemicals 3801 Saint Elmo Avenue,
Chattanooga, Tennessee 37409, applied
to be registered as a bulk manufacturer
of the following basic class(es) of
controlled substance(s):
SUPPLEMENTARY INFORMATION:
Controlled substance
Drug
code
Gamma Hydroxybutyric Acid ....
Marihuana .................................
Tetrahydrocannabinols .............
4-Methoxyamphetamine ...........
Dihydromorphine .......................
Norlevorphanol ..........................
Amphetamine ............................
Methamphetamine ....................
Lisdexamfetamine .....................
Methylphenidate ........................
ANPP (4-Anilino-N-phenethyl-4piperidine).
Phenylacetone ..........................
Cocaine .....................................
Codeine .....................................
Dihydrocodeine .........................
Oxycodone ................................
Hydromorphone ........................
Hydrocodone .............................
Levorphanol ..............................
Meperidine ................................
Meperidine intermediate–A .......
Meperidine intermediate–B .......
Meperidine intermediate–C .......
Methadone ................................
Methadone intermediate ...........
Morphine ...................................
Oripavine ...................................
Thebaine ...................................
Opium, powdered .....................
Opium, granulated ....................
Oxymorphone ...........................
Noroxymorphone ......................
Racemethorphan ......................
Alfentanil ...................................
Remifentanil ..............................
Sufentanil ..................................
Tapentadol ................................
Fentanyl ....................................
Schedule
2010
7360
7370
7411
9145
9634
1100
1105
1205
1724
8333
I
I
I
I
I
I
II
II
II
II
II
8501
9041
9050
9120
9143
9150
9193
9220
9230
9232
9233
9234
9250
9254
9300
9330
9333
9639
9640
9652
9668
9732
9737
9739
9740
9780
9801
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
[FR Doc. 2021–03836 Filed 2–24–21; 8:45 am]
BILLING CODE 4410–09–P
VerDate Sep<11>2014
17:04 Feb 24, 2021
Jkt 253001
Drug Enforcement Administration
[Docket No. DEA–791]
Bulk Manufacturer of Controlled
Substances Application: S&B Pharma,
Inc.
Drug Enforcement
Administration, Justice.
AGENCY:
ACTION:
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before April 26, 2021. Such persons
may also file a written request for a
hearing on the application on or before
April 26, 2021.
DATES:
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
ADDRESSES:
In
accordance with 21 CFR 1301.33(a), this
is notice that on November 11, 2020,
S&B Pharma, Inc., 405 South Motor
Avenue, Azusa, California 91702–3232,
applied to be registered as an bulk
manufacturer of the following basic
class(es) of controlled substance(s):
SUPPLEMENTARY INFORMATION:
Gamma Hydroxybutyric Acid ....
Tetrahydrocannabinols .............
Amphetamine ............................
Methamphetamine ....................
Lisdexamfetamine .....................
Methylphenidate ........................
Pentobarbital .............................
4-Anilino-N-phenethyl-4-piperidine (ANPP).
Tapentadol ................................
Fentanyl ....................................
Drug
code
Schedule
7360
7370
1100
1105
1205
1724
2270
8333
I
I
II
II
II
II
II
II
9780
9801
II
II
The company plans to manufacture
the listed controlled substances in bulk
for use in product development and for
commercial sales to its customers. In
reference to drug code 7360 (Marihuana)
and 7370 (Tetrahydrocannabinols), the
company plans to bulk manufacture
both as synthetic substances. No other
Frm 00064
Fmt 4703
DEPARTMENT OF JUSTICE
[Docket No. DEA798]
Notice of application.
Controlled substance
BILLING CODE 4410–09–P
Drug Enforcement Administration
S&B Pharma, Inc., has applied
to be registered as a bulk manufacturer
of basic class(es) of controlled
substance(s). Refer to Supplemental
Information listed below for further
drug information.
PO 00000
William T. McDermott,
Assistant Administrator.
[FR Doc. 2021–03837 Filed 2–24–21; 8:45 am]
SUMMARY:
The company plans to manufacturer
the listed controlled substances in bulk
for distribution and sale to its
customers.
In reference to drug code 7360
(Marihuana) and 7370
(Tetrahydrocannabinols), the company
plans to bulk manufacture these drugs
as a synthetic. No other activities for
this drug code are authorized for this
registration.
William T. McDermott,
Assistant Administrator.
activity for these drug codes is
authorized for this registration.
DEPARTMENT OF JUSTICE
Sfmt 4703
Importer of Controlled Substances
Application: Myonex Inc
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Myonex Inc has applied to be
registered as an importer of basic
class(es) of controlled substance(s).
Refer to Supplemental Information
listed below for further drug
information.
SUMMARY:
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before March 29, 2021. Such persons
may also file a written request for a
hearing on the application on or before
March 29, 2021.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All request for a hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.34(a), this
is notice that on January 6, 2021,
Myonex Inc, 48 East Main Street,
Norristown, Pennsylvania 19401–4915,
applied to be registered as an importer
of the following basic class(es) of
controlled substance(s):
DATES:
Controlled substance
Amphetamine .................
Lisdexamfetamine ..........
Methylphenidate .............
E:\FR\FM\25FEN1.SGM
25FEN1
Drug
code
Schedule
1100
1205
1724
II
II
II
]]>Agencies
[Federal Register Volume 86, Number 36 (Thursday, February 25, 2021)]
[Notices]
[Page 11558]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-03837]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-791]
Bulk Manufacturer of Controlled Substances Application: S&B
Pharma, Inc.
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: S&B Pharma, Inc., has applied to be registered as a bulk
manufacturer of basic class(es) of controlled substance(s). Refer to
Supplemental Information listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may file written comments on or objections to
the issuance of the proposed registration on or before April 26, 2021.
Such persons may also file a written request for a hearing on the
application on or before April 26, 2021.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
is notice that on November 11, 2020, S&B Pharma, Inc., 405 South Motor
Avenue, Azusa, California 91702-3232, applied to be registered as an
bulk manufacturer of the following basic class(es) of controlled
substance(s):
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Gamma Hydroxybutyric Acid............... 7360 I
Tetrahydrocannabinols................... 7370 I
Amphetamine............................. 1100 II
Methamphetamine......................... 1105 II
Lisdexamfetamine........................ 1205 II
Methylphenidate......................... 1724 II
Pentobarbital........................... 2270 II
4-Anilino-N-phenethyl-4-piperidine 8333 II
(ANPP).
Tapentadol.............................. 9780 II
Fentanyl................................ 9801 II
------------------------------------------------------------------------
The company plans to manufacture the listed controlled substances
in bulk for use in product development and for commercial sales to its
customers. In reference to drug code 7360 (Marihuana) and 7370
(Tetrahydrocannabinols), the company plans to bulk manufacture both as
synthetic substances. No other activity for these drug codes is
authorized for this registration.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2021-03837 Filed 2-24-21; 8:45 am]
BILLING CODE 4410-09-P
